The Future of Pharma​ – Looking Ahead to 2026

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Future of pharma report: explore drug development trends, regulatory shifts, clinical pipelines, and market opportunities shaping the biopharmaceutical industry.

Understand Where the Pharmaceutical Industry Is Heading

The pharmaceutical industry is entering a phase of rapid transformation, driven by shifts in drug development, regulation, and market dynamics.

This report provides a clear, high-level view of both near-term and long-term changes shaping the industry, helping you understand how these shifts impact strategy, investment, and innovation.

It brings together regulatory, clinical, and market-based analysis to highlight the major forces influencing the future of pharma.

Report Value Proposition – Why This Matters for You

This report helps you cut through complexity and focus on what actually matters.

You can use it to:

  • Identify emerging trends shaping drug development
  • Track regulatory and clinical shifts impacting pipelines
  • Spot near-term opportunities and potential risks
  • Align investment and business development strategies
  • Understand which companies and areas are gaining momentum

Key Insights in the Future of Pharma

The industry is being shaped by a combination of regulatory developments, clinical pipeline evolution, and shifting market dynamics.

Short-term changes in 2026 are expected to influence both opportunities and risks, while longer-term trends will define how the market evolves over the next five years.

Clinical activity continues to play a central role, with ongoing and planned trials offering insight into where innovation is heading.

At the same time, sales forecasts and pipeline analysis provide a forward-looking view of future growth areas.

Scope

What You Will Learn

A forward-looking view of the pharmaceutical industry, including:

  • Key trends shaping drug development
  • Regulatory and clinical shifts influencing the market
  • Opportunities and threats expected in 2026
  • Long-term opportunities projected over the next five years
  • Clinical trial activity and pipeline developments

Target Buyers for This Report

This report is designed for decision-makers across the pharmaceutical ecosystem:

  • Pharma and biotech companies
  • Business development and investment teams
  • Strategy and market intelligence professionals
  • Investors and advisors

How Companies Use This Report

  • Pharmaceutical companies
    Align portfolios with future drug development trends
  • Business development teams
    Identify partnership and investment opportunities
  • Investors and analysts
    Evaluate companies and emerging growth areas
  • Strategy and market intelligence teams
    Track industry shifts and competitive positioning

Reasons to Buy

Benchmark Trends, Pipelines and Market Shifts

The report provides a structured view of key industry movements:

  • Regulatory and Market Analysis
    Understand how regulatory changes and market conditions are shaping the industry.
  • Clinical Pipeline Insights
    Track ongoing and planned clinical trials and their impact on future development.
  • Sales Forecasts
    Explore projections that highlight future opportunities and risks.
  • Company Positioning
    Identify which companies are expected to lead in the near and long term.

Built on Trusted Data and Expert Analysis

This report combines multiple layers of insight to deliver a clear industry outlook.

  • Includes regulatory, clinical, and market-based analysis
  • Supported by sales forecasts and pipeline data
  • Features 28 figures illustrating key trends and projections

Act Now to Stay Ahead of Pharma Transformation

The future of pharma is being shaped now through clinical innovation, regulatory shifts, and evolving market dynamics.

This report gives you the clarity to identify opportunities, manage risks, and position your strategy for what’s next.

If you are planning investments, partnerships, or portfolio strategy, this is where you gain direction.

GSK plc
Bristol-Myers Squibb Co
AstraZeneca Plc
Novartis AG
F. Hoffmann-La Roche Ltd
Merck & Co Inc
Johnson & Johnson
Sanofi
Pfizer Inc
AbbVie Inc
Eli Lilly and Co
Biogen Inc
UCB Pharma
Otsuka Pharmaceutical Co Ltd
Amgen Inc
Merck KGaA
Novo Nordisk AS
Regeneron Pharmaceuticals Inc
Genentech
Gilead Sciences
AddPharma
Avidity Biosciences Inc
Bio-Thera Solutions Inc
Boehringer Ingelheim
Concept Therapeutics
CSPC Pharmaceutical Group Ltd
InSilico Medicine
Jiangsu Hengrui Pharmaceuticals Co Ltd
MannKind Corp
Orca Biosystems
Revolution Medicines Inc
Structure Therapeutics Inc
Summit Therapeutics Inc
Travere Therapeutics Inc
Vanda Pharmaceuticals Inc

Table of Contents

1 Year Ahead Opportunities

1.1 The Most Impactful Emerging Industry Trends

1.2 Top 10 Companies by Pharmaceutical Sales 2025 vs. 2026

1.3 Top 10 Late-Stage Companies

1.4 Top 10 Key Therapy Areas, 2025 vs. 2026

1.5 Top 10 Drugs, 2025 vs. 2026

1.6 PDUFA Dates

1.7 Top 10 Drug Launches in 2026

1.8 Top 10 Targets in the Pipeline

2 Year Ahead Threats

2.1 Drug Patent Expirations

2.2 Post-Marketing Obligations

3 Future Opportunities

3.1 Risk-Adjusted Net Present Value

3.2 Sales Five Years from Now

3.3 Top Drug Licensing Opportunities

4 Clinical Trials

4.1 Clinical Trial Sponsors in 2026

5 Key Findings

6 Appendix

6.1 Abbreviations

6.2 Methodology

6.3 About the Authors

6.4 About GlobalData

6.5 Contact Us

The Future of Pharma​ – Looking Ahead to 2026 thematic reports
Currency USD
$1,200

Can be used by individual purchaser only

$2,700

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

The Future of Pharma​ – Looking Ahead to 2026 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at The Future of Pharma​ – Looking Ahead to 2026 in real time.

  • Access a live The Future of Pharma​ – Looking Ahead to 2026 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.